← FDA Drug Approvals (Drugs@FDA)
ASTAGRAF XL
NDA · New Drug Application · Sponsor: ASTELLAS · Approved 2013-07-19
Drug application
- FDA Application #
NDA204096
- Application type
- New Drug Application
- Brand name
- ASTAGRAF XL
- Generic name
- TACROLIMUS EXTENDED-RELEASE CAPSULES
- Active ingredients
- TACROLIMUS
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ASTELLAS
- Manufacturer
- Astellas Pharma US, Inc.
- First approval
- 2013-07-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown